CRISPR Therapeutics AGCRSP
那斯達克 · USD
51.84
-5.11
(-8.97%)
收盤 06/06 03:59 (UTC+8)
盤後
51.96
+0.12
(+0.23%)
06/06 03:59 (UTC+8)
CRISPR Therapeutics AGCRSP
51.84
-5.11
(-8.97%)
財務數據
損益表
- 2.01
- 0.01
- 0.01
- 0.01
- 0.36
- 0.01
- 0.01
- 0.01
- 0.01
- 0.01
- -
- -99.75
- 2.58
- 16.44
- 5828.74
- -97.58
- 3.12
- -0.34
- -2.81
- 68.75
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 1,458 | 864 | 889 | 892 | 865 | 35,691 | 602 | 517 | 504 | 201,206 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,458 | 864 | 889 | 892 | 865 | 35,691 | 602 | 517 | 504 | 201,206 |
營業費用 | 131,706 | 155,628 | 132,948 | 230,216 | - | - | - | 151,778 | - | 131,623 |
研發費用 | 68,574 | 83,526 | 58,902 | 69,894 | 72,484 | 82,155 | 82,160 | 80,166 | 76,172 | 95,144 |
推銷及管理費用 | 63,132 | 72,102 | 74,046 | 64,069 | 76,805 | 18,124 | 28,572 | 71,612 | 64,919 | 36,479 |
非經常性項目費用 | - | - | - | 96,253 | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -130,248 | -154,764 | -132,059 | -229,324 | -148,424 | -64,588 | -110,130 | -151,261 | -140,587 | 69,583 |
其他收入及費用 | 8,156 | 24,765 | 26,237 | 22,067 | 13,537 | 27,977 | 25,064 | 26,140 | 24,720 | 19,997 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -122,092 | -129,999 | -105,822 | -207,257 | -134,887 | -36,611 | -85,066 | -125,121 | -115,867 | 89,580 |
所得稅 | 839 | 614 | 619 | 1,292 | 1,109 | 700 | 876 | 1,287 | 724 | 233 |
稅後純益 | -122,931 | -130,613 | -106,441 | -208,549 | -135,996 | -37,311 | -85,942 | -126,408 | -116,591 | 89,347 |
基本每股稅後盈餘(元) | -1.28 | -1.32 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | - |
稀釋每股稅後盈餘(元) | -1.28 | -1.35 | -1.14 | -2.40 | -1.58 | -0.42 | -1.00 | -1.49 | -1.43 | 1.13 |
基本平均股數(千股) | 96051.00 | 95388.00 | 91305.00 | 87069.00 | 85938.00 | 85464.00 | 85234.00 | 84920.00 | 81794.00 | - |
稀釋平均股數(千股) | 96051.00 | 95388.00 | 91305.00 | 87069.00 | 85938.00 | 85464.00 | 85234.00 | 84920.00 | 81794.00 | - |
還原基本每股稅後盈餘(元) | -1.28 | -1.32 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | - |
還原稀釋每股稅後盈餘(元) | -1.28 | -1.35 | -1.14 | -2.40 | -1.58 | -0.42 | -1.00 | -1.49 | -1.43 | 1.13 |
還原基本平均股數(千股) | 96,051 | 95,388 | 91,305 | 87,069 | 85,938 | 85,464 | 85,234 | 84,920 | 81,794 | - |
還原稀釋平均股數(千股) | 96,051 | 95,388 | 91,305 | 87,069 | 85,938 | 85,464 | 85,234 | 84,920 | 81,794 | - |
EBITDA(千元) | -117,773 | -124,338 | -101,389 | -202,608 | -130,151 | -31,769 | -80,327 | -120,276 | -111,034 | 94,480 |